🧠 At a glance:
- FY25 PAT: ₹1,911 crore (+15% YoY)
- Revenue: ₹11,516 crore (+7%)
- Q4 PAT: ₹498 crore (+11%)
- Dividend: ₹6/share final, ₹26/share interim = ₹32/share total
👨⚕️ About the Company
Torrent Pharma is the Amitabh Bachchan of Indian pharma – veteran, versatile, and always in the race. It operates in key therapies like cardiology, diabetology, gastro, CNS, and women’s health with presence in India, US, Germany, Brazil, and other markets.
🧑💼 Key Managerial Personnel (KMP)
- Chairman: Samir Mehta
- MD (Incoming): Aman Mehta (taking charge from 1 August 2025)
